Literature DB >> 33248388

NELF complex fosters BRCA1 and RAD51 recruitment to DNA damage sites and modulates sensitivity to PARP inhibition.

Laila A Bishara1, Feras E Machour2, Samah W Awwad3, Nabieh Ayoub4.   

Abstract

The negative elongation factor (NELF) is a four-subunit protein complex (NELF-E, NELF-A, NELF-B and NELF-C/D) that negatively regulates transcription elongation of RNA polymerase II (Pol II). Interestingly, upregulation of NELF-E subunit promotes hepatocellular carcinoma (HCC) and pancreatic cancer. In addition, we have previously shown that NELF complex fosters double-strand break (DSB)-induced transcription silencing and promotes homology-directed repair (HDR). However, the mechanisms underlying NELF-E regulation of HDR of DSBs remain unknown. Here, we show that NELF-E interacts with BRCA1 and promotes its recruitment to laser-microirradiated sites and facilitates ionizing radiation-induced foci (IRIF) of BRCA1 in HCC cells (Hep3B). The reduction in BRCA1 IRIF is accompanied by decreased RAD51 IRIF. A corollary to this, NELF-E-deficient Hep3B cells exhibit defective HDR of chromosomal DSBs induced by CRISPR-Cas9 system. Consequently, the disruption of NELF complex integrity, by NELF-E downregulation, sensitizes Hep3B cells to PARP inhibition. Altogether, our results suggest that NELF promotes HDR by facilitating BRCA1 and RAD51 IRIF formation and identify NELF complex as a novel synthetic lethal partner of PARP1.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BRCA1; Double-strand break (DSB); Hepatocellular carcinoma (HCC); Homology-directed repair (HDR); NELF-E; Negative elongation factor (NELF); RAD51

Year:  2020        PMID: 33248388     DOI: 10.1016/j.dnarep.2020.103025

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  2 in total

1.  Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC).

Authors:  Masanori Oshi; Tae Hee Kim; Yoshihisa Tokumaru; Li Yan; Ryusei Matsuyama; Itaru Endo; Leonid Cherkassky; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-01-17       Impact factor: 6.639

Review 2.  The Emerging Roles of Rad51 in Cancer and Its Potential as a Therapeutic Target.

Authors:  Ziyi Wang; Renxiang Jia; Linlin Wang; Qiwei Yang; Xiaohai Hu; Qiang Fu; Xinyu Zhang; Wenya Li; Yi Ren
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.